Ibrutinib Impurity 157
- CASnot assigned
- CatalogueRS-I001AVY
- FormulaC20H17N5O2
- MW359.14
IN STOCK
On this page
Product identification
| Product name | Ibrutinib Impurity 157 |
|---|---|
| Catalogue No. | RS-I001AVY |
| CAS No. | not assigned |
| Molecular formula | C20H17N5O2 |
| Molecular weight | 359.14 |
| Availability | In stock— dispatched in about 1–2 weeks |
| Standard type | Impurity Reference Standards |
| Drug substance | Ibrutinib |
| Storage | Refer to the certificate of analysis (COA) supplied with each lot |
| Intended use | For laboratory and research use only. Not for human or veterinary use. |
What is stated on the certificate
Content and purity are assigned per lot and stated on the certificate of analysis issued for the batch you receive — they are not a catalogue-level figure. The certificate records the tests performed, the specification applied and the result obtained for that lot.
| Field | Basis |
|---|---|
| Identity | Spectroscopic and chromatographic methods appropriate to the material |
| Purity | Chromatographic purity, area normalisation unless stated otherwise |
| Assay / content | Mass balance, corrected for the stated volatiles and residue |
| Catalogue and batch numbers | RS-I001AVY / batch number on the certificate |
| Retest date | Printed on the certificate for the lot supplied |
Frequently asked
What documentation is supplied with this lot?
A certificate of analysis (COA) is issued for the lot you receive. It records the catalogue number
RS-I001AVY and the batch number, the tests performed, the
specification applied and the result obtained. A safety data sheet is supplied with the shipment.
Is the assigned value given on an “as is” basis?
Content and purity are stated per lot on the certificate of analysis, on an “as is” basis unless the certificate says otherwise. The analytical basis for the assigned value is stated on the certificate.
How should this material be stored?
Store as stated: Refer to the certificate of analysis (COA) supplied with each lot. Re-test before use beyond the retest date printed on the certificate.
Do you supply pack sizes other than those listed?
Pack sizes are confirmed with the quotation. Quantities beyond the standard pack sizes can be quoted — send the quantity you need with your enquiry.
Finding this standard
Buyers reach this compound by CAS number, by catalogue number, through the drug substance it belongs to, or through the type of standard it is. Those routes all start here:
- Other impurities of Ibrutinib
- Impurity Reference Standards of this kind
- Documents for this item (COA, SDS)
- Certificate of analysis for RS-I001AVY
- Request a quotation for RS-I001AVY
Searching another way? Send the structure, a SMILES string or the pharmacopoeial name — a CAS number is not required for a non-compendial impurity. Write to sales@rssechem.com.
Other standards of Ibrutinib
All 146 further standards are listed here — every link is in the page, not loaded later.
-
(S)-Ibrutinib
IN STOCKRS-I011151 -
Ibrutinib
IN STOCKRS-I005030 -
(2e)-1-(3-hydroxypiperidin-1-yl)-3-phenylprop-2-en-1-one
BACK ORDERRS-U008806 -
(R)-1-(3-Hydroxypiperidin-1-yl)prop-2-en-1-one
IN STOCKRS-I024351 -
(R)-1-Boc-3-hydroxypiperidine
IN STOCKRS-C031006 -
(R)-1-N-Boc-3-Methanesulfonyloxypiperidine
BACK ORDERRS-U080774 -
(R)-N-(3-(4-phenoxyphenyl)-1-(piperidin-3-yl)-1Hpyrazolo[
BACK ORDERRS-I009332 -
(S)-1-(3-Hydroxypiperidin-1-yl)prop-2-en-1-one
IN STOCKRS-U079101 -
(S)-3-(4-phenoxyphenyl)-1-(piperidin-3-yl)-1H-pyrazolo[3,4-d]pyrimidin-4-amine
BACK ORDERRS-U079100 -
(S)-tert-butyl 3-((methylsulfonyl)oxy)piperidine-1-carboxylate
IN STOCKRS-C050053 -
1-(3-Hydroxypiperidin-1-yl)prop-2-en-1-one
CUSTOM SYNTHESISRS-I024352 -
1-BOC-4-hydroxypiperidine
IN STOCKRS-U005121 -
2-(4-Phenoxybenzoyl)malononitrile
IN STOCKRS-P017326 -
2-Phenoxybenzoic Acid
IN STOCKRS-C006018 -
3-Methoxypropanoyl Chloride
IN STOCKRS-P011980 -
4,6-Diaminopyrimidine-5-Carbaldehyde
CUSTOM SYNTHESISRS-U211LH9 -
4-Aminopyrazolo[3,4-d]pyrimidine
IN STOCKRS-U089126 -
5-Amino-3-(4-phenoxyphenyl)-1H-pyrazole-4-carboxamide
IN STOCKRS-U089590 -
5-Methyl-N,N diphenylpyridin-2-amine
IN STOCKRS-U085070 -
5-methyl-N-phenyl-2-aminopyridine
CUSTOM SYNTHESISRS-U085158 -
6-Chloro-1H-pyrazolo[3,4-b]pyrazine
IN STOCKRS-C003013 -
Ibrutinib-biotin
CUSTOM SYNTHESISRS-I024026 -
Ibrutinib-d5
IN STOCKRS-I003106 -
N-Nitroso (S)-Piperidin-3-ol
IN STOCKRS-N001344 -
N-Piperidine ibrutinib hydrochloride
BACK ORDERRS-I024073 -
Remibrutinib(LOU064)
BACK ORDERRS-U080593 -
tert-Butyl (R)-3-(4-amino-3-bromo-1H-pyrazolo[3,4-d]pyrimidin-1-yl)piperidine-1-carboxylate
CUSTOM SYNTHESISRS-Z398SY1 -
tert-Butyl 3-bromo-4-hydroxy-1H-pyrazolo[3,4-d]pyrimidine-1-carboxylate
IN STOCKRS-Z399IIJ -
Ibrutinib Impurity 7
IN STOCKRS-I001BGE -
Ibrutinib Impurity 8
IN STOCKRS-I024015 -
Zanubrutinib Impurity 9
BACK ORDERRS-Z412OH5 -
Ibrutinib Impurity 18(Hydrochloride)
CUSTOM SYNTHESISRS-I024025 -
Ibrutinib Impurity 20-d9
IN STOCKRS-I024327 -
Ibrutinib Impurity 38
BACK ORDERRS-I001APX -
Ibrutinib Impurity 39
CUSTOM SYNTHESISRS-I001874 -
Ibrutinib Impurity 48
CUSTOM SYNTHESISRS-Z412M9E -
Ibrutinib Impurity 58-d8
CUSTOM SYNTHESISRS-I024322 -
Ibrutinib Impurity 65
CUSTOM SYNTHESISRS-I001BOB -
Ibrutinib Impurity 68
BACK ORDERRS-I001B5N -
Ibrutinib Impurity 77
CUSTOM SYNTHESISRS-I001AAW -
Ibrutinib Impurity 98
CUSTOM SYNTHESISRS-I024318 -
Ibrutinib Impurity 110
IN STOCKRS-I024079 -
Ibrutinib Impurity 113
BACK ORDERRS-I001AD5 -
Ibrutinib Impurity 124
IN STOCKRS-I001B4L -
Ibrutinib Impurity 137
CUSTOM SYNTHESISRS-I001A81 -
Ibrutinib Impurity 144
IN STOCKRS-I001BEV -
Ibrutinib Impurity 164
BACK ORDERRS-I001B2Y -
Ibrutinib Impurity 182
IN STOCKRS-I024061 -
Ibrutinib Impurity 183
IN STOCKRS-I024082 -
Ibrutinib Impurity 194 (N-Nitroso Ibrutinib Impurity 44)
BACK ORDERRS-I024075 -
Ibrutinib Impurity 199
IN STOCKRS-I024313 -
Ibrutinib Impurity 201
IN STOCKRS-I024059 -
Ibrutinib Impurity 219
IN STOCKRS-I024040 -
Ibrutinib Impurity 222
IN STOCKRS-I024001 -
Ibrutinib Impurity 223
IN STOCKRS-I024002 -
Ibrutinib Impurity 224
IN STOCKRS-I024003 -
Ibrutinib Impurity 225
IN STOCKRS-I024005 -
Ibrutinib Impurity 226
IN STOCKRS-I024008 -
Ibrutinib Impurity 227
IN STOCKRS-I024011 -
Ibrutinib Impurity 228
IN STOCKRS-I024013 -
Ibrutinib Impurity 229
BACK ORDERRS-I024017 -
Ibrutinib Impurity 230
IN STOCKRS-I024021 -
Ibrutinib Impurity 231
BACK ORDERRS-I024027 -
Ibrutinib Impurity 232
IN STOCKRS-I024028 -
Ibrutinib Impurity 233
IN STOCKRS-I024029 -
Ibrutinib Impurity 234
BACK ORDERRS-I024030 -
Ibrutinib Impurity 235
IN STOCKRS-I024031 -
Ibrutinib Impurity 236
BACK ORDERRS-I024035 -
Ibrutinib Impurity 237
BACK ORDERRS-I024038 -
Ibrutinib Impurity 238
IN STOCKRS-I024041 -
Ibrutinib Impurity 239
IN STOCKRS-I024042 -
Ibrutinib Impurity 240
IN STOCKRS-I024043 -
Ibrutinib Impurity 241
IN STOCKRS-I024046 -
Ibrutinib Impurity 242
BACK ORDERRS-I024047 -
Ibrutinib Impurity 243
BACK ORDERRS-I024049 -
Ibrutinib Impurity 244
IN STOCKRS-I024051 -
Ibrutinib Impurity 245
IN STOCKRS-I024053 -
Ibrutinib Impurity 246
BACK ORDERRS-I024054 -
Ibrutinib Impurity 247
BACK ORDERRS-I024056 -
Ibrutinib Impurity 248
IN STOCKRS-I024057 -
Ibrutinib Impurity 249
IN STOCKRS-I024062 -
Ibrutinib Impurity 250
BACK ORDERRS-I024064 -
Ibrutinib Impurity 251
BACK ORDERRS-I024065 -
Ibrutinib Impurity 252
IN STOCKRS-I024066 -
Ibrutinib Impurity 253
IN STOCKRS-I024069 -
Ibrutinib Impurity 254
BACK ORDERRS-I024070 -
Ibrutinib Impurity 255
IN STOCKRS-I024072 -
Ibrutinib Impurity 256
IN STOCKRS-I024074 -
Ibrutinib Impurity 257
IN STOCKRS-I024081 -
Ibrutinib Impurity 279
CUSTOM SYNTHESISRS-I024315 -
Ibrutinib Impurity 280
IN STOCKRS-I024319 -
Ibrutinib Impurity 284
IN STOCKRS-I024332 -
Ibrutinib Impurity 285
BACK ORDERRS-I024334 -
Ibrutinib Impurity 289
BACK ORDERRS-I024338 -
Ibrutinib Impurity 291
BACK ORDERRS-I024345 -
Ibrutinib Impurity 294
BACK ORDERRS-I024349 -
Ibrutinib Impurity 314
IN STOCKRS-U011043 -
Ibrutinib Impurity 315
IN STOCKRS-U015055 -
Ibrutinib Impurity 317
CUSTOM SYNTHESISRS-I024004 -
Ibrutinib Impurity 318
IN STOCKRS-I024006 -
Ibrutinib Impurity 319
CUSTOM SYNTHESISRS-I024007 -
Ibrutinib Impurity 320
IN STOCKRS-I024009 -
Ibrutinib Impurity 321
BACK ORDERRS-I024010 -
Ibrutinib Impurity 322
IN STOCKRS-I024012 -
Ibrutinib Impurity 323
IN STOCKRS-I024014 -
Ibrutinib Impurity 324
IN STOCKRS-I024016 -
Ibrutinib Impurity 325
IN STOCKRS-I024018 -
Ibrutinib Impurity 327
BACK ORDERRS-I024020 -
Ibrutinib Impurity 328
IN STOCKRS-I024022 -
Ibrutinib Impurity 329
IN STOCKRS-I024023 -
Ibrutinib Impurity 330
IN STOCKRS-I024024 -
Ibrutinib Impurity 331
IN STOCKRS-I024032 -
Ibrutinib Impurity 332
IN STOCKRS-I024033 -
Ibrutinib Impurity 333
IN STOCKRS-I024034 -
Ibrutinib Impurity 334
IN STOCKRS-I024036 -
Ibrutinib Impurity 335
IN STOCKRS-I024037 -
Ibrutinib Impurity 336
BACK ORDERRS-I024039 -
Ibrutinib Impurity 337
IN STOCKRS-I024044 -
Ibrutinib Impurity 338
IN STOCKRS-I024045 -
Ibrutinib Impurity 339
CUSTOM SYNTHESISRS-I024048 -
Ibrutinib Impurity 341
IN STOCKRS-I024052 -
Ibrutinib Impurity 342
BACK ORDERRS-I024055 -
Ibrutinib Impurity 344
CUSTOM SYNTHESISRS-I024060 -
Ibrutinib Impurity 345
IN STOCKRS-I024063 -
Ibrutinib Impurity 347
CUSTOM SYNTHESISRS-I024071 -
Ibrutinib Impurity 348
BACK ORDERRS-I024076 -
Ibrutinib Impurity 349
IN STOCKRS-I024077 -
Ibrutinib Impurity 350
CUSTOM SYNTHESISRS-I024078 -
Ibrutinib Impurity 351
IN STOCKRS-I024080 -
Ibrutinib Impurity 406
CUSTOM SYNTHESISRS-I024312 -
Ibrutinib Impurity 407
IN STOCKRS-I024314 -
Ibrutinib Impurity 408
IN STOCKRS-I024316 -
Ibrutinib Impurity 409
IN STOCKRS-I024317 -
Ibrutinib Impurity 410
BACK ORDERRS-I024320 -
Ibrutinib Impurity 418
BACK ORDERRS-I024343 -
Ibrutinib Impurity 421
IN STOCKRS-I024350 -
Ibrutinib Impurity 512
IN STOCKRS-I027009 -
Ibrutinib Impurity 513
IN STOCKRS-U003211 -
Ibrutinib Impurity 514
BACK ORDERRS-U096676 -
Ibrutinib Impurity 515
CUSTOM SYNTHESISRS-I024330 -
Ibrutinib Impurity 516
IN STOCKRS-I024331
![Chemical structure of (1R)-1-(1-Acryloylpiperidin-3-yl)-4-amino-3-(4-phenoxyphenyl)-1H-pyrazolo[3,4-d]pyrimidine 1-oxide](/structures/w4/WHNVUBNAXFVNTG-BQYWNOCXSA-N.webp?v=8)
![Chemical structure of (R)-3-(4-Phenoxyphenyl)-1-(piperidin-3-yl)-1H-pyrazolo[3,4-d]pyrimidin-4-amine Dihydrochloride](/structures/w4/ZGTOUEKDPROJPB-UHFFFAOYSA-N.webp?v=8)
![Chemical structure of (S)-3-(4-phenoxyphenyl)-1-(piperidin-3-yl)-1H-pyrazolo[3,4-d]pyrimidin-4-amine](/structures/w4/ATLAMSZMAHXMSQ-NTISSMGPSA-N.webp?v=8)
![Chemical structure of 1-((R)-3-(4-Amino-3-(4-(phenoxy-D5)phenyl)-1H-pyrazolo[3,4-d]pyrimidin-1-yl)piperidin-1-yl)-2,3-dihydroxypropan-1-one](/structures/w4/NWKPMPRXJGMTKQ-ROSSWGEHSA-N.webp?v=8)
![Chemical structure of 2-Propen-1-one, 1-[(3R)-3-[4-amino-3-(4-phenoxyphenyl)-1H-pyrazolo[3,4-d]pyrimidin-1-yl]-1-piperidinyl]-2-methyl-](/structures/w4/SVIZVWRMNNDHOC-LJQANCHMSA-N.webp?v=8)
![Chemical structure of 4-Aminopyrazolo[3,4-d]pyrimidine](/structures/w4/LHCPRYRLDOSKHK-UHFFFAOYSA-N.webp?v=8)
![Chemical structure of 6-Chloro-1H-pyrazolo[3,4-b]pyrazine](/structures/w4/PGTUKZWBYWVLHW-UHFFFAOYSA-N.webp?v=8)
![Chemical structure of tert-Butyl (R)-3-(3-(4-phenoxyphenyl)-4-((triphenyl-l5-phosphaneylidene)amino)-1H-pyrazolo[3,4-d]pyrimidin-1-yl)piperidine-1-carboxylate](/structures/w4/ARECIKOLCWUROL-UUWRZZSWSA-N.webp?v=8)
![Chemical structure of tert-Butyl (R)-3-(4-amino-3-bromo-1H-pyrazolo[3,4-d]pyrimidin-1-yl)piperidine-1-carboxylate](/structures/w4/VHATZAIZPHOHET-SECBINFHSA-N.webp?v=8)
![Chemical structure of tert-Butyl 3-bromo-4-hydroxy-1H-pyrazolo[3,4-d]pyrimidine-1-carboxylate](/structures/w4/ZZMJFNPXSYBVMR-UHFFFAOYSA-N.webp?v=8)
Pharmacopoeial names (EP, USP, BP, JP) are used for identification purposes only and do not imply endorsement by those bodies. This product is supplied for laboratory and research use only — not for human or veterinary use.